caffeine citrate has been researched along with Cerebral Hemorrhage in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, RM; Saroha, V | 1 |
| Firman, B; Gray, PH; Molnar, A | 1 |
| Bendel-Stenzel, E; Chhabra, R; Harper, B; Ku, L; Laughon, M; Moya, F; Payne, EH; Puia-Dumitrescu, M; Smith, PB; Soriano, A; Wade, KC; Zhao, J | 1 |
1 review(s) available for caffeine citrate and Cerebral Hemorrhage
| Article | Year |
|---|---|
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2020 |
2 other study(ies) available for caffeine citrate and Cerebral Hemorrhage
| Article | Year |
|---|---|
Early high-dose caffeine citrate for extremely preterm infants: Neonatal and neurodevelopmental outcomes.
Topics: Adult; Caffeine; Cerebral Hemorrhage; Citrates; Databases, Factual; Dose-Response Relationship, Drug; Gestational Age; Humans; Infant, Extremely Premature; Morbidity; Outcome Assessment, Health Care; Retrospective Studies; Risk Assessment | 2019 |
Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Ductus Arteriosus, Patent; Electronic Health Records; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Multivariate Analysis; Off-Label Use; Treatment Outcome | 2019 |